TFBS Bioscience (ROCO:6939) Operating Margin %: -34.00% (As of Dec. 2025)


ROCO:6939 TFBS Bioscience Inc ROCO:6939
49 GF Score
Price NT$20.60
GF Value NT$32.17
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Operating Margin %?

TFBS Bioscience ROCO:6939 -0.48% 49 Operating Margin % is -34.00% as of Dec. 2025. GuruFocus rates ROCO:6939 with a GF Score™ of 49/100 and a GF Value™ of NT$32.17 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, TFBS Bioscience ranks worse than 75.98% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. TFBS Bioscience's Operating Income for the six months ended in Dec. 2025 was NT$-36.1 Mil. TFBS Bioscience's Revenue for the six months ended in Dec. 2025 was NT$106.2 Mil. Therefore, TFBS Bioscience's Operating Margin % for the quarter that ended in Dec. 2025 was -34.00%.

The historical rank and industry rank for TFBS Bioscience's Operating Margin % or its related term are showing as below:

ROCO:6939' s Operating Margin % Range Over the Past 10 Years
Min: -40.39   Med: -0.83   Max: 13.36
Current: -40.39


ROCO:6939's Operating Margin % is ranked worse than
75.98% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs ROCO:6939: -40.39

TFBS Bioscience's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

TFBS Bioscience's Operating Income for the six months ended in Dec. 2025 was NT$-36.1 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-78.0 Mil.

Warning Sign:

TFBS Bioscience Inc has never been profitable in the past 3 years. It lost money every year.


TFBS Bioscience  (ROCO:6939) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


TFBS Bioscience Operating Margin % Related Terms


TFBS Bioscience Operating Margin % Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Operating Margin % Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial 3.73 13.36 -1.92 -33.91 -40.39

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.53 -28.23 -39.77 -48.17 -34.00

ROCO:6939 vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, TFBS Bioscience's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TFBS Bioscience Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's Operating Margin % distribution charts can be found below:

* The bar in red indicates where TFBS Bioscience's Operating Margin % falls into.


ROCO:6939
49GF Score
TFBS Bioscience Inc ROCO:6939
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TFBS Bioscience Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

TFBS Bioscience's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-78.001 / 193.142
=-40.39 %

TFBS Bioscience's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-36.097 / 106.155
=-34.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -34.00% mean?
TFBS Bioscience (ROCO:6939) has a Operating Margin % of -34.00% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on TFBS Bioscience and its competitors. According to the industry distribution chart, TFBS Bioscience ranks #155 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 76%.
Is TFBS Bioscience's Operating Margin % too high?
TFBS Bioscience's current Operating Margin % is -34.00%. Based on the distribution chart, TFBS Bioscience ranks #155 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, TFBS Bioscience ranks #155 out of 204 companies for Operating Margin %. This places TFBS Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on TFBS Bioscience and its competitors. TFBS Bioscience's current Operating Margin % is -34.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.17, compared to a current price of NT$20.60 — trading 36% below its estimated fair value. The current Operating Margin % is -34.00%. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Operating Margin % is -34.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.60 is trading 36% below its estimated GF Value™ of NT$32.17. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Operating Margin %: -34.00%
  • GF Value™: NT$32.17 vs. price of NT$20.60 (36% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score

Get the complete analysis for ROCO:6939

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.60
Price
NT$32.17
GF Value